| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/25/2006 | EP1001757B1 Fast-acting analgesic |
| 01/25/2006 | CN1726216A C-6 modified indazolylpyrrolotriazines |
| 01/25/2006 | CN1726215A [1,7]naphthyridines as PDE4 inhibitors |
| 01/25/2006 | CN1726213A Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 01/25/2006 | CN1726198A Compounds, compositions, and methods |
| 01/25/2006 | CN1726023A Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
| 01/25/2006 | CN1726022A Pregabalin derivatives for the treatment of fibromyalgia and other disorders and its derivitive |
| 01/25/2006 | CN1726021A Alpha2delta ligands for the treatment of sexual dysfunction |
| 01/25/2006 | CN1726015A Alpha2delta ligands for different pharmaceutical uses |
| 01/25/2006 | CN1724063A Method for producing turmeric stable prepn. |
| 01/25/2006 | CN1724052A External application medicine for treating appendicitis, and its prepn. method |
| 01/25/2006 | CN1724049A Medicinal composition for treating swelling paint |
| 01/25/2006 | CN1724023A Method for preparing Qingkailing |
| 01/25/2006 | CN1724014A Extractive of total saponin of clematis root, prepn. method and pharmaceutical use thereof |
| 01/25/2006 | CN1724013A Traditional Chinese medicinal prepn. for treating obstruction of qi in the chest |
| 01/25/2006 | CN1724008A Traditional Chinese medicine |
| 01/25/2006 | CN1724002A Medicinal composition, and its pharmaceutical use |
| 01/25/2006 | CN1723978A Pain-relieving |
| 01/25/2006 | CN1723966A Compound traditional Chinese medicine for treating fracture and injury, prepn. method and use thereof |
| 01/25/2006 | CN1723940A External use medicinal liquor for dispelling wind |
| 01/25/2006 | CN1723928A External use medicinal composition for treating swelling paint |
| 01/25/2006 | CN1723883A Nimesulide sustained release medicinal composition |
| 01/25/2006 | CN1238354C Analog of nerve growth factor (2S, 4S)-2-(2'substituent)-4-(indole-3-methine)-5,5-disubstituent group-1, 3-f azole alkane compound, preparation method and application thereof |
| 01/25/2006 | CN1238341C 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 01/25/2006 | CN1238330C Salts of asiatic and madecassic acid suitable for preparation of pharmaceutical and cosmetic compositions |
| 01/25/2006 | CN1238050C Traditional Chinese medicinal paste for treating arthralgia-syndrome and preparation method thereof |
| 01/25/2006 | CN1238049C Traditional Chinese medicine paste for treating arthralgia-syndrome |
| 01/25/2006 | CN1238048C Chinese traditional medicine for treating arthralgia -syndrome and its preparation |
| 01/25/2006 | CN1238047C Adhesive plaster for treating arthralgia and formula |
| 01/25/2006 | CN1238042C Shoulder pain treating Chinese medicine and its preparation process |
| 01/25/2006 | CN1238020C Medicine for treating waist and lower extremities pain |
| 01/25/2006 | CN1238019C Oil for comforting channels and collaterals |
| 01/25/2006 | CN1238018C Plaster for treating pain in neck, shoulder, waist and lower extremities |
| 01/25/2006 | CN1238017C Preparation method of rheumatic osteodynia plaster |
| 01/25/2006 | CN1238015C Adhesive plaster for treating traumatic injury pain |
| 01/25/2006 | CN1238013C Myocarditis treating Chinese medicine preparation |
| 01/25/2006 | CN1238000C Freeze-dried powder injection Qingkailing preparation process |
| 01/25/2006 | CN1237996C Wind dispelling cold eliminating medicinal wine and its preparation method |
| 01/25/2006 | CN1237982C Cactus primary juice and its preparation method and application |
| 01/25/2006 | CN1237975C Application of general saponin of gen-seng fruit in the preparation process of myocarditis treating medicine |
| 01/25/2006 | CN1237972C Active component of muskrat fragrant, preparing technique and usage |
| 01/25/2006 | CN1237969C Remedial agent for chronic articular rheumatism |
| 01/25/2006 | CN1237964C Method for preparing granules containing brufen arginine composition |
| 01/25/2006 | CN1237960C Preparation method of aspirin microsphere |
| 01/25/2006 | CN1237959C Process for preparing pharmaceutical compositions for use with soft capsule |
| 01/24/2006 | US6989401 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989388 Antitumor agents; anticancer agents; antiischemic agents; antiinflamamtory agents |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | CA2386828C Novel pseudoerythromycin derivatives |
| 01/24/2006 | CA2368431C Melanocortin receptor ligands |
| 01/24/2006 | CA2339353C Fast dissolving orally consumable films |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2205757C Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii) |
| 01/20/2006 | CA2512531A1 Use of compounds derived from 2,3-dehydronaringenin for the treatment of inflammatory processes and pharmaceutical composition containing said derivatives |
| 01/19/2006 | WO2006006741A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006006577A1 Loxoprofen-containing composition for oral administration |
| 01/19/2006 | US20060015054 External plaster containing 4-biphenylacetic acid |
| 01/19/2006 | US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014831 e.g. 2-[(2-methoxyphenyl)(1-naphthyl)methyl]malononitrile; antiinflammatory and hypoglycemic agent; rheumatoid arthritis, osteoarthritis, psoriatic and juvenile arthritis, inflammatory bowel disease, Crohn's disease, ulcerative and indeterminate colitis, psoriasis, asthma, hyperlipidemia |
| 01/19/2006 | US20060014804 Cyanoguanidine prodrugs |
| 01/19/2006 | US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 01/19/2006 | US20060014794 CXCR1 and CXCR2 chemokine antagonists |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060014730 Ansamycin formulations and methods for producing and using same |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060013877 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | US20060013818 Method of treating granuloma annulare or sarcoid |
| 01/19/2006 | US20060013775 Use of ppar activators for the treatment of pulmonary fibrosis |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616871A1 Porphyrin compound containing biotinyl group and use thereof |
| 01/18/2006 | EP1616869A1 Substituted porphyrins and their therapeutic use |
| 01/18/2006 | EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616856A1 Novel transcriptional factor, process for producing the same and use thereof |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1616566A1 Lipoxin compounds for treating TNF-alpha initiated inflammation |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615907A1 5-amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseases |
| 01/18/2006 | EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions |
| 01/18/2006 | EP1615699A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 01/18/2006 | EP1501505B1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -triazole for the treatment of autoimmune diseases |
| 01/18/2006 | EP1470138B1 Mmp inhibitors |
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |